Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Olanzapine-induced mania

R R Reeves1, W A McBride, G E Brannon

  • 1G. V. (Sonny) Montgomery VA Medical Center, Jackson, MS 39216, USA.

The Journal of the American Osteopathic Association
|November 20, 1998
PubMed
Summary
This summary is machine-generated.

Olanzapine effectively treats schizophrenia symptoms but can paradoxically induce mania. This case highlights a potential complication of olanzapine treatment that clinicians should monitor.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Narwhals require targeted conservation.

Science (New York, N.Y.)·2020
Same author

Physical and ecological effects of rehabilitating the geothermally influenced Waikite Wetland, New Zealand.

Journal of environmental management·2018
Same author

Subphenotyping and Classification of Orofacial Clefts: Need for Orofacial Cleft Subphenotyping Calls for Revised Classification.

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association·2015
Same author

Reliability, completeness and accuracy of cleft subphenotyping as recorded on the CLEFTSiS (Cleft Service in Scotland) electronic patient record.

The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland·2013
Same author

Efficacy of behavioural interventions in managing atypical antipsychotic weight gain.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2009
Same author

Reactions of Veterans Administration psychiatric patients to the September 2001 terrorist attacks.

Southern medical journal·2002
Same journal

2020 AOA Research Abstracts and Poster Competition.

The Journal of the American Osteopathic Association·2020
Same journal

Communication Skills of Grandview/Southview Medical Center General Surgery Residents.

The Journal of the American Osteopathic Association·2020
Same journal

[PREPRINT] "Somebody Who Does Something Other Than Osteopathy".

The Journal of the American Osteopathic Association·2020
Same journal

Toward Resilience: Medical Students' Perception of Social Support.

The Journal of the American Osteopathic Association·2020
Same journal

Comparison of State Medical Licensing Board Disclosures Regarding Resident Performance for United States Allopathic, Osteopathic, and Foreign Medical Graduates.

The Journal of the American Osteopathic Association·2020
Same journal

Remdesivir for the Treatment of Severe COVID-19: A Community Hospital's Experience.

The Journal of the American Osteopathic Association·2020
See all related articles

Area of Science:

  • Psychiatry
  • Pharmacology

Background:

  • Olanzapine is an atypical antipsychotic used for schizophrenia treatment.
  • It targets both positive and negative symptoms of schizophrenia.

Observation:

  • A case report details a patient experiencing manic symptoms.
  • These symptoms emerged during olanzapine therapy.

Findings:

  • The patient developed mania as a secondary effect of olanzapine treatment.
  • This suggests a potential adverse reaction to the medication.

Implications:

  • Clinicians should be aware of the risk of olanzapine-induced mania.
  • Careful patient monitoring is necessary during olanzapine treatment.